These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22512618)

  • 41. Novel imidazo[1,2-a]pyrazine derivatives as potent reversible inhibitors of the gastric H+/K+-ATPase.
    Zimmermann PJ; Brehm C; Buhr W; Palmer AM; Volz J; Simon WA
    Bioorg Med Chem; 2008 Jan; 16(1):536-41. PubMed ID: 17964794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect on gastric mucus of the proton pump inhibitor leminoprazole and its cytoprotective action against ethanol-induced gastric injury in rats.
    Ishihara K; Ichikawa T; Komuro Y; Ohara S; Hotta K
    Arzneimittelforschung; 1994 Jul; 44(7):827-30. PubMed ID: 7945516
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The binding selectivity of vonoprazan (TAK-438) to the gastric H+, K+ -ATPase.
    Scott DR; Munson KB; Marcus EA; Lambrecht NW; Sachs G
    Aliment Pharmacol Ther; 2015 Dec; 42(11-12):1315-26. PubMed ID: 26423447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-ulcerogenic and proton pump (H+, K+ ATPase) inhibitory activity of Kolaviron from Garcinia kola Heckel in rodents.
    Onasanwo SA; Singh N; Olaleye SB; Palit G
    Indian J Exp Biol; 2011 Jun; 49(6):461-8. PubMed ID: 21702226
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversible inhibition of rat gastric H+/K+-ATPase by T-330, 2-[2-dimethylaminobenzyl)sulfinyl]-1-(3-methylpyridine-2-yl)imidazole.
    Kinoshita M; Saito N; Noto T; Tamaki H
    J Pharmacol Exp Ther; 1996 Apr; 277(1):28-33. PubMed ID: 8613931
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Proton pump inhibitors].
    Schubert-Zsilavecz M; Stark H
    Pharm Unserer Zeit; 2005; 34(3):194-9. PubMed ID: 15940951
    [No Abstract]   [Full Text] [Related]  

  • 47. Management of GERD: Are Potassium-Competitive Acid Blockers Superior to Proton Pump Inhibitors?
    Kinoshita Y; Ishimura N; Ishihara S
    Am J Gastroenterol; 2018 Oct; 113(10):1417-1419. PubMed ID: 29955116
    [No Abstract]   [Full Text] [Related]  

  • 48. Substituted pyrrol-1-ylacetic acids that combine aldose reductase enzyme inhibitory activity and ability to prevent the nonenzymatic irreversible modification of proteins from monosaccharides.
    Nicolaou I; Demopoulos VJ
    J Med Chem; 2003 Jan; 46(3):417-26. PubMed ID: 12540241
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and biological activity of 2-anilino-4-(1H-pyrrol-3-yl) pyrimidine CDK inhibitors.
    Wang S; Wood G; Meades C; Griffiths G; Midgley C; McNae I; McInnes C; Anderson S; Jackson W; Mezna M; Yuill R; Walkinshaw M; Fischer PM
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4237-40. PubMed ID: 15261277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification, characterization, and high-performance liquid chromatography quantification of process-related impurities in vonoprazan fumarate.
    Liu L; Cao N; Ma X; Xiong K; Sun L; Zou Q
    J Sep Sci; 2016 Apr; 39(7):1232-41. PubMed ID: 26843471
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel and one-pot synthesis of new 1-tosyl pyrrol-2-one derivatives and analysis of carbonic anhydrase inhibitory potencies.
    Alp C; Ekinci D; Gültekin MS; Sentürk M; Sahin E; Küfrevioğlu OI
    Bioorg Med Chem; 2010 Jun; 18(12):4468-74. PubMed ID: 20554206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proton pump inhibitors in the management of GORD and PUD.
    Kenny E
    Ir Med J; 1993; 86(4):114. PubMed ID: 8395486
    [No Abstract]   [Full Text] [Related]  

  • 53. Characteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438).
    Otake K; Sakurai Y; Nishida H; Fukui H; Tagawa Y; Yamasaki H; Karashima M; Otsuka K; Inatomi N
    Adv Ther; 2016 Jul; 33(7):1140-57. PubMed ID: 27287852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro pharmacological characterization of a novel allosteric modulator of alpha 7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profile.
    Malysz J; Grønlien JH; Anderson DJ; Håkerud M; Thorin-Hagene K; Ween H; Wetterstrand C; Briggs CA; Faghih R; Bunnelle WH; Gopalakrishnan M
    J Pharmacol Exp Ther; 2009 Jul; 330(1):257-67. PubMed ID: 19389923
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel 1H-pyrrolo[2,3-c]pyridines as acid pump antagonists (APAs).
    Yoon YA; Kim DH; Lee BM; Kim TK; Cha MH; Sim JY; Kim JG
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5237-40. PubMed ID: 20656486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of gastric H+, K+-ATPase by 3-amino-5-methyl-2-(2-methyl-3-thienyl)imidazo[1,2-a]thieno[3,2-c]pyrid ine, SPI-447.
    Ushiro T; Tsukimi Y; Tanaka H
    Jpn J Pharmacol; 1997 Nov; 75(3):303-6. PubMed ID: 9434264
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-activity relations on [1-(3,5-difluoro-4-hydroxyphenyl)-1H-pyrrol-3-yl]phenylmethanone. The effect of methoxy substitution on aldose reductase inhibitory activity and selectivity.
    Chatzopoulou M; Mamadou E; Juskova M; Koukoulitsa C; Nicolaou I; Stefek M; Demopoulos VJ
    Bioorg Med Chem; 2011 Feb; 19(4):1426-33. PubMed ID: 21288726
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of gastric H+, K(+)-ATPase activity by compounds from medicinal plants.
    Freitas CS; Baggio CH; Mayer B; dos Santos AC; Twardowschy A; Santos CA; Marques MC
    Nat Prod Commun; 2011 Sep; 6(9):1253-4. PubMed ID: 21941891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pharmacological characteristics and clinical efficacies of a novel potassium-competitive acid blocker, vonoprazan fumarate].
    Matsukawa J; Inatomi N; Nishida H; Tsukimi Y
    Nihon Yakurigaku Zasshi; 2018; 152(3):104-110. PubMed ID: 30185727
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Substituted methoxybenzyl-sulfonyl-1H-benzo[d]imidazoles evaluated as effective H
    Rajesh R; Manikandan A; Sivakumar A; Ramasubbu C; Nagaraju N
    Eur J Med Chem; 2017 Oct; 139():454-460. PubMed ID: 28818769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.